PL394569A1 - Asymetrycznie podstawione pochodne antrapirydazonu jako cytostatyki modulujace opornosc wielolekowa komórek nowotworowych - Google Patents

Asymetrycznie podstawione pochodne antrapirydazonu jako cytostatyki modulujace opornosc wielolekowa komórek nowotworowych

Info

Publication number
PL394569A1
PL394569A1 PL394569A PL39456911A PL394569A1 PL 394569 A1 PL394569 A1 PL 394569A1 PL 394569 A PL394569 A PL 394569A PL 39456911 A PL39456911 A PL 39456911A PL 394569 A1 PL394569 A1 PL 394569A1
Authority
PL
Poland
Prior art keywords
cytostatics
tumor cells
multidrug resistance
antrapyridazone
asymmetrically substituted
Prior art date
Application number
PL394569A
Other languages
English (en)
Inventor
Edward Borowski
Barbara Stefańska
Maria Dzieduszycka
Marcin Cybulski
Wiesław Szelejewski
Janusz Obukowicz
Maria Bontemps-Gracz
Małgorzata Wysocka
Jan Mazerski
Joanna Wietrzyk
Paweł Punda
Original Assignee
Instytut Farmaceutyczny
Politechnika Gdańska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Farmaceutyczny, Politechnika Gdańska filed Critical Instytut Farmaceutyczny
Priority to PL394569A priority Critical patent/PL394569A1/pl
Priority to BR112013026190A priority patent/BR112013026190A2/pt
Priority to KR1020137030144A priority patent/KR20140027995A/ko
Priority to EP12722932.6A priority patent/EP2697205A1/en
Priority to JP2014505102A priority patent/JP6013451B2/ja
Priority to CA2831388A priority patent/CA2831388A1/en
Priority to AU2012243487A priority patent/AU2012243487A1/en
Priority to PCT/PL2012/000025 priority patent/WO2012141604A1/en
Priority to US14/111,022 priority patent/US9096536B2/en
Publication of PL394569A1 publication Critical patent/PL394569A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/36—Benzo-cinnolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems
PL394569A 2011-04-14 2011-04-14 Asymetrycznie podstawione pochodne antrapirydazonu jako cytostatyki modulujace opornosc wielolekowa komórek nowotworowych PL394569A1 (pl)

Priority Applications (9)

Application Number Priority Date Filing Date Title
PL394569A PL394569A1 (pl) 2011-04-14 2011-04-14 Asymetrycznie podstawione pochodne antrapirydazonu jako cytostatyki modulujace opornosc wielolekowa komórek nowotworowych
BR112013026190A BR112013026190A2 (pt) 2011-04-14 2012-04-13 derivados de antrapiridazona assimetricamente substituídos como citostáticos
KR1020137030144A KR20140027995A (ko) 2011-04-14 2012-04-13 세포증식억제제로서의 비대칭 치환된 안트라피리다존 유도체
EP12722932.6A EP2697205A1 (en) 2011-04-14 2012-04-13 Asymmetrically substituted anthrapyridazone derivatives as cytostatics
JP2014505102A JP6013451B2 (ja) 2011-04-14 2012-04-13 細胞増殖抑制剤としての非対称に置換されたアントラピリダゾン誘導体
CA2831388A CA2831388A1 (en) 2011-04-14 2012-04-13 Asymmetrically substituted anthrapyridazone derivatives as cytostatics
AU2012243487A AU2012243487A1 (en) 2011-04-14 2012-04-13 Asymmetrically substituted anthrapyridazone derivatives as cytostatics
PCT/PL2012/000025 WO2012141604A1 (en) 2011-04-14 2012-04-13 Asymmetrically substituted anthrapyridazone derivatives as cytostatics
US14/111,022 US9096536B2 (en) 2011-04-14 2012-04-13 Asymmetrically substituted anthrapyridazone derivatives as cytostatics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL394569A PL394569A1 (pl) 2011-04-14 2011-04-14 Asymetrycznie podstawione pochodne antrapirydazonu jako cytostatyki modulujace opornosc wielolekowa komórek nowotworowych

Publications (1)

Publication Number Publication Date
PL394569A1 true PL394569A1 (pl) 2012-10-22

Family

ID=46147661

Family Applications (1)

Application Number Title Priority Date Filing Date
PL394569A PL394569A1 (pl) 2011-04-14 2011-04-14 Asymetrycznie podstawione pochodne antrapirydazonu jako cytostatyki modulujace opornosc wielolekowa komórek nowotworowych

Country Status (9)

Country Link
US (1) US9096536B2 (pl)
EP (1) EP2697205A1 (pl)
JP (1) JP6013451B2 (pl)
KR (1) KR20140027995A (pl)
AU (1) AU2012243487A1 (pl)
BR (1) BR112013026190A2 (pl)
CA (1) CA2831388A1 (pl)
PL (1) PL394569A1 (pl)
WO (1) WO2012141604A1 (pl)

Also Published As

Publication number Publication date
CA2831388A1 (en) 2012-10-18
US20140031357A1 (en) 2014-01-30
WO2012141604A1 (en) 2012-10-18
US9096536B2 (en) 2015-08-04
JP2014515022A (ja) 2014-06-26
AU2012243487A1 (en) 2013-10-17
BR112013026190A2 (pt) 2019-09-24
KR20140027995A (ko) 2014-03-07
JP6013451B2 (ja) 2016-10-26
EP2697205A1 (en) 2014-02-19

Similar Documents

Publication Publication Date Title
CA2900335C (en) Synthetic analogs of epipolythiodioxopiperazines and uses thereof
MX354021B (es) Derivados de 5-fluor-4-imino-3- (sustituido) -3,4-dihidropirimidin -2 (1h) ona.
PH12016500643A1 (en) New octahydro - cyclobuta [1,2-c;3,4-c`] dipyrrol -2- yl
NZ603151A (en) N3-substituted-n1-sulfonyl-5-fluoropyrimidinone derivatives
MX358682B (es) Derivados de pirazolo [1,5a]pirimidina y de tieno[3,2b] pirimidina como moduladores de la cinasa asociada al receptor de la interleucina 4 (irak4).
MX2019009100A (es) Nuevos derivados de triazolo[4,5-d]pirimidina.
MY170878A (en) [1,2,3] triazolo [4,5-d] pyrimidine derivatives as agonists of the cannabinoid receptor 2
MA33939B1 (fr) 5-alcynyl-pyrimidines
WO2015077635A3 (en) Macromolecular antioxidants based on dual type moiety per molecule: structures methods of making and using the same
WO2012078902A3 (en) Proteostasis regulators
MY161132A (en) Novel herbicides
MX2012008141A (es) Compuestos y metodos.
MX2011007932A (es) Herbicidas nuevos.
PH12015500716A1 (en) N-prop-2-ynyl carboxamide derivatives and their use as trpa1 antagonists
MX346248B (es) Derivados de [1,2,3]triazol[4,5-d]pirimidina como agonistas de los agonistas del receptor canabinoide 2.
NZ597570A (en) N1-acyl-5-fluoropyrimidinone derivatives
MY149154A (en) Novel microbiocides
PL394569A1 (pl) Asymetrycznie podstawione pochodne antrapirydazonu jako cytostatyki modulujace opornosc wielolekowa komórek nowotworowych
MX2012014290A (es) Agentes anti-inflamatorios.
UA63370U (en) Use of 4,3'-spiro[(2-amino-3-cyano-4,5-dihydropyrano[3,2-c]chromen-5-on)-5-methyl-2'-oxyndole] as nephroprotective agent
UA56041U (ru) 1,3-диметил-7-n-метилбензил-8-гидразиноксантин, который проявляет диуретическое действие
UA79655U (en) Compounds n-para-methoxyphenyl-3-(7'-theophylline-8'-bromo)-succinimide and n-ortho-methoxyphenyl-3-(7'-theophylline-8with potential physiological properties
UA79866U (ru) Применение 2-оксоиндолин-3-глиоксиловой кислоты в качестве средств с антидепрессивным действием
UA75945U (uk) Діетиламід 2,7-дихлор-4-метилхінолін-6-сульфонової кислоти, який проявляє діуретичну активність
UA53926U (ru) Пиперидиния 1,3,7-триметилимидазо[1,2-f]ксантинил-8-ацетат, который проявляет диуретическое действие